Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Manzano

Showing results (161-170 of 179) with videos related to

Pageof 18
Sort By:
Cancer Chemotherapy and Pharmacology|December 11, 2014
Phase II trial of miniDOX (reduced dose docetaxel-oxaliplatin-capecitabine) in "suboptimal" patients with advanced gastric cancer (AGC). TTD 08-02F Rivera, B Massutí, M Salcedo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2019
Ultra-selection of metastatic colorectal cancer patients using next-generation sequencing to improve clinical efficacy of anti-EGFR therapyJ Vidal, B Bellosillo, C Santos Vivas, et al.
Melanoma Research|September 15, 2015
BRAF mutation analysis in circulating free tumor DNA of melanoma patients treated with BRAF inhibitorsMaria Gonzalez-Cao, Clara Mayo-de-Las-Casas, Miguel A Molina-Vila, et al.
The Lancet. Gastroenterology & Hepatology|January 19, 2020
Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 studyPhilip A Philip, Jill Lacy, Fabienne Portales, et al.
Nature Communications|May 23, 2023
Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung originJ Capdevila, J Hernando, A Teule, et al.
Revista Clinica Espanola|March 10, 2018
Positioning document on incorporating point-of-care ultrasound in Internal Medicine departmentsJ Torres Macho, F J García Sánchez, P Garmilla Ezquerra, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 6, 2017
Pembrolizumab for advanced melanoma: experience from the Spanish Expanded Access ProgramM González-Cao, A Arance, J M Piulats, et al.
Digestive Diseases and Sciences|January 13, 2017
Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular CarcinomaMar Riveiro-Barciela, David Tabernero, José L Calleja, et al.
International Journal of Cancer|September 30, 2017
Sentinel lymph node biopsy versus observation in thick melanoma: A multicenter propensity score matching studyAram Boada, Antonio Tejera-Vaquerizo, Simone Ribero, et al.
ESMO Open|September 4, 2025
Clinical validation of liquid biopsy-RECIST (LB-RECIST) in metastatic colorectal cancer (mCRC) patients: findings from the PLATFORM-B studyV Martelli, J Vidal, J Gibert, et al.
Pageof 18

Showing results (161-170 of 179) with videos related to

Sort By:
Pageof 18
Cancer Chemotherapy and Pharmacology|December 11, 2014
Phase II trial of miniDOX (reduced dose docetaxel-oxaliplatin-capecitabine) in "suboptimal" patients with advanced gastric cancer (AGC). TTD 08-02F Rivera, B Massutí, M Salcedo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2019
Ultra-selection of metastatic colorectal cancer patients using next-generation sequencing to improve clinical efficacy of anti-EGFR therapyJ Vidal, B Bellosillo, C Santos Vivas, et al.
Melanoma Research|September 15, 2015
BRAF mutation analysis in circulating free tumor DNA of melanoma patients treated with BRAF inhibitorsMaria Gonzalez-Cao, Clara Mayo-de-Las-Casas, Miguel A Molina-Vila, et al.
The Lancet. Gastroenterology & Hepatology|January 19, 2020
Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 studyPhilip A Philip, Jill Lacy, Fabienne Portales, et al.
Nature Communications|May 23, 2023
Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung originJ Capdevila, J Hernando, A Teule, et al.
Revista Clinica Espanola|March 10, 2018
Positioning document on incorporating point-of-care ultrasound in Internal Medicine departmentsJ Torres Macho, F J García Sánchez, P Garmilla Ezquerra, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 6, 2017
Pembrolizumab for advanced melanoma: experience from the Spanish Expanded Access ProgramM González-Cao, A Arance, J M Piulats, et al.
Digestive Diseases and Sciences|January 13, 2017
Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular CarcinomaMar Riveiro-Barciela, David Tabernero, José L Calleja, et al.
International Journal of Cancer|September 30, 2017
Sentinel lymph node biopsy versus observation in thick melanoma: A multicenter propensity score matching studyAram Boada, Antonio Tejera-Vaquerizo, Simone Ribero, et al.
ESMO Open|September 4, 2025
Clinical validation of liquid biopsy-RECIST (LB-RECIST) in metastatic colorectal cancer (mCRC) patients: findings from the PLATFORM-B studyV Martelli, J Vidal, J Gibert, et al.
Pageof 18